The Assessment of Convalescent Plasma Efficacy against COVID-19

Antibody-based therapy for infectious diseases predates modern antibiotics and, in the absence of other therapeutic options, was deployed early in the SARS-CoV-2 pandemic through COVID-19 convalescent plasma (CCP) administration. Although most studies have demonstrated signals of efficacy for CCP, d...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Med (N Y)
Päätekijät: Casadevall, Arturo, Grossman, Brenda J., Henderson, Jeffrey P., Joyner, Michael J., Shoham, Shmuel, Pirofski, Liise-anne, Paneth, Nigel
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier Inc. 2020
Aiheet:
Perspective
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7747676/
https://ncbi.nlm.nih.gov/pubmed/33363284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.medj.2020.11.002
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia